Stromal type I collagen in breast cancer: correlation to prognostic biomarkers and prediction of chemotherapy response

Introduction Fibrillar collagens accumulate in the breast cancer stroma and appear as poorly defined spiculated masses in mammography imaging. The prognostic value of tissue type I collagen remains elusive in treatment-naïve and chemotherapy-treated breast cancer patients. Here, type I collagen mRNA and protein expression were analysed in two large independent breast cancer cohorts. Levels were related to clinicopathological parameters, prognostic biomarkers, and outcome. Method COL1A1 mRNA expression was analysed in 2509 patients with breast cancer obtained from the cBioPortal database. Type I collagen protein expression was studied by immunohistochemistry in 1395 women diagnosed with early invasive breast cancer. Results Low COL1A1 mRNA and protein levels correlated with poor prognosis features, such as hormone receptor negativity, high histological grade, triple-negative subtype, node positivity, and tumour size. In unadjusted analysis, high stromal type I collagen protein expression was associated with improved overall survival (OS) (HR = 0.78, 95% CI = 0.61–0.99, p = 0.043) and trended towards improved breast cancer–specific survival (BCSS) (HR = 0.65, 95% CI = 0.42–1.01, p = 0.053), although these findings were lost after adjustment for other clinical variables. In unadjusted analysis, high expression of type I collagen was associated with better OS (HR = 0.70, 95% CI = 0.55–0.90, p = 0.006) and BCSS (HR = 0.55, 95% CI = 0.34–0.88, p = 0.014) among patients not receiving chemotherapy. Strikingly, the opposite was observed among patients receiving chemotherapy. There, high expression of type I collagen was instead associated with worse OS (HR = 1.83, 95% CI = 0.65–5.14, p = 0.25) and BCSS (HR = 1.72, 95% CI = 0.54–5.50, p = 0.357). Conclusion Low stromal type I collagen mRNA and protein expression are associated with unfavourable tumour characteristics in breast cancer. Stromal type I collagen might predict chemotherapy response. MicroAbstract Type I collagen is involved in the development and progression of breast cancer. Here, type I collagen mRNA and protein expression were analysed in 2509 and 1395 breast cancer patients, respectively. Results show that low type I collagen expression is a marker of more aggressive breast cancer, and also a predictive biomarker of response to adjuvant chemotherapy.